Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth M Jaffee

Showing results (201-210 of 291) with videos related to

Pageof 30
Sort By:
Cancer Cell|May 15, 2014
Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasiaFlorencia McAllister, Jennifer M Bailey, Janivette Alsina, et al.
JCI Insight|December 8, 2023
CD4 T cell-activating neoantigens enhance personalized cancer vaccine efficacyAmanda L Huff, Gabriella Longway, Jacob T Mitchell, et al.
Cancer Research|February 8, 2024
Fibroblasts in the Aged Pancreas Drive Pancreatic Cancer ProgressionDaniel J Zabransky, Yash Chhabra, Mitchell E Fane, et al.
Cancer Immunology Research|August 24, 2019
Immunopathologic Stratification of Colorectal Cancer for Checkpoint Blockade ImmunotherapyNicolas J Llosa, Brandon Luber, Nicholas Siegel, et al.
Hepatology (Baltimore, Md.)|August 9, 2022
Profiling of syngeneic mouse HCC tumor models as a framework to understand anti-PD-1 sensitive tumor microenvironmentsDaniel J Zabransky, Ludmila Danilova, James M Leatherman, et al.
International Journal of Radiation Oncology, Biology, Physics|November 15, 2024
Phase 1 Study of Adjuvant Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor-Transduced Pancreatic Tumor Cell Vaccine, Low-Dose Cyclophosphamide, and Stereotactic Body Radiation Therapy Followed by FOLFIRINOX in High-Risk Resected Pancreatic Ductal AdenocarcinomaColin S Hill, Rose Parkinson, Elizabeth M Jaffee, et al.
Nature Protocols|November 21, 2023
Inferring cellular and molecular processes in single-cell data with non-negative matrix factorization using Python, R and GenePattern Notebook implementations of CoGAPSJeanette A I Johnson, Ashley P Tsang, Jacob T Mitchell, et al.
International Journal of Cancer|May 17, 2014
Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survivalAlessandra De Remigis, Tanja D de Gruijl, Jennifer N Uram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2021
Phase I Study of Entinostat and Nivolumab with or without Ipilimumab in Advanced Solid Tumors (ETCTN-9844)Evanthia T Roussos Torres, Christine Rafie, Chenguang Wang, et al.
Nature Medicine|April 7, 2024
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trialMark Yarchoan, Edward J Gane, Thomas U Marron, et al.
Pageof 30

Showing results (201-210 of 291) with videos related to

Sort By:
Pageof 30
Cancer Cell|May 15, 2014
Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasiaFlorencia McAllister, Jennifer M Bailey, Janivette Alsina, et al.
JCI Insight|December 8, 2023
CD4 T cell-activating neoantigens enhance personalized cancer vaccine efficacyAmanda L Huff, Gabriella Longway, Jacob T Mitchell, et al.
Cancer Research|February 8, 2024
Fibroblasts in the Aged Pancreas Drive Pancreatic Cancer ProgressionDaniel J Zabransky, Yash Chhabra, Mitchell E Fane, et al.
Cancer Immunology Research|August 24, 2019
Immunopathologic Stratification of Colorectal Cancer for Checkpoint Blockade ImmunotherapyNicolas J Llosa, Brandon Luber, Nicholas Siegel, et al.
Hepatology (Baltimore, Md.)|August 9, 2022
Profiling of syngeneic mouse HCC tumor models as a framework to understand anti-PD-1 sensitive tumor microenvironmentsDaniel J Zabransky, Ludmila Danilova, James M Leatherman, et al.
International Journal of Radiation Oncology, Biology, Physics|November 15, 2024
Phase 1 Study of Adjuvant Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor-Transduced Pancreatic Tumor Cell Vaccine, Low-Dose Cyclophosphamide, and Stereotactic Body Radiation Therapy Followed by FOLFIRINOX in High-Risk Resected Pancreatic Ductal AdenocarcinomaColin S Hill, Rose Parkinson, Elizabeth M Jaffee, et al.
Nature Protocols|November 21, 2023
Inferring cellular and molecular processes in single-cell data with non-negative matrix factorization using Python, R and GenePattern Notebook implementations of CoGAPSJeanette A I Johnson, Ashley P Tsang, Jacob T Mitchell, et al.
International Journal of Cancer|May 17, 2014
Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survivalAlessandra De Remigis, Tanja D de Gruijl, Jennifer N Uram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2021
Phase I Study of Entinostat and Nivolumab with or without Ipilimumab in Advanced Solid Tumors (ETCTN-9844)Evanthia T Roussos Torres, Christine Rafie, Chenguang Wang, et al.
Nature Medicine|April 7, 2024
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trialMark Yarchoan, Edward J Gane, Thomas U Marron, et al.
Pageof 30